Ogawa Tomoyuki, Takeno Sachio, Ishino Takashi, Hirakawa Katsuhiro
Department of Otolaryngology, Head and Neck Surgery, Division of Clinical Medical Science, Programs for Applied Biomedicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Auris Nasus Larynx. 2007 Sep;34(3):319-26. doi: 10.1016/j.anl.2007.01.008. Epub 2007 Apr 11.
Submucous resection of the inferior turbinate is one of the recommended methods to alleviate nasal symptoms in patients with severe allergic rhinitis patients in terms of postoperative results and preservation of nasal function. Posterior nasal neurectomy, recently developed by Kikawada, is a novel method to selectively cut the neural bundles out from the sphenopalatine foramen and to diminish the complaints of hypersecretion. This study was carried to examine the clinical effectiveness and changes in local cytokine levels of this combined surgical procedure.
Twenty-three patients with severe perennial allergic rhinitis underwent submucous turbinectomy combined with posterior nasal neurectomy under general anesthesia. The patients' subjective nasal symptoms were examined at each visit. The levels of interleukin-5 (IL-5), eotaxin and regulated on activation, normal T cell expressed and secreted (RANTES) in nasal lavages were measured before and 6 month after surgery. Nasal mucosa of the inferior turbinate was also obtained for histopathological examination in some cases.
The mean symptom scores for sneeze, rhinorrhea, nasal obstruction, and total severity were all statistically decreased after surgery. Therapeutic effects continued to be apparent as long as 3 years after surgery. The mean levels of both IL-5 and eotaxin significantly decreased after surgery, but that of RANTES remained unchanged. Histopathological examination revealed that the number of inflammatory cells and nasal glands markedly reduced in lamina propria and the epithelial layer became covered with stratified columnar cells.
Submucosal turbinectomy with posterior nasal neurectomy has remarkably improved subjective nasal symptoms in patients with severe allergic rhinitis on a long-term follow-up basis. The present study also demonstrates that the clinical effectiveness of the procedure is accompanied by decreases in local inflammatory cell infiltration and the related cytokine production.
就术后效果和鼻功能保留而言,下鼻甲黏膜下切除术是缓解重度变应性鼻炎患者鼻部症状的推荐方法之一。Kikawada最近研发的鼻后神经切除术是一种选择性地从蝶腭孔切断神经束并减轻分泌物过多症状的新方法。本研究旨在探讨这种联合手术的临床疗效及局部细胞因子水平的变化。
23例重度常年性变应性鼻炎患者在全身麻醉下接受下鼻甲黏膜下切除术联合鼻后神经切除术。每次复诊时检查患者的主观鼻部症状。在术前及术后6个月测量鼻灌洗液中白细胞介素-5(IL-5)、嗜酸性粒细胞趋化因子及正常T细胞激活后表达和分泌的调节蛋白(RANTES)水平。部分病例还获取下鼻甲鼻黏膜进行组织病理学检查。
术后喷嚏、流涕、鼻塞及总体严重程度的平均症状评分均有统计学意义的下降。治疗效果在术后长达3年时仍很明显。术后IL-5和嗜酸性粒细胞趋化因子的平均水平均显著下降,但RANTES水平未变。组织病理学检查显示,固有层炎性细胞和鼻腺数量明显减少,上皮层被复层柱状上皮覆盖。
长期随访显示,下鼻甲黏膜下切除术联合鼻后神经切除术可显著改善重度变应性鼻炎患者的主观鼻部症状。本研究还表明,该手术的临床疗效伴随着局部炎性细胞浸润及相关细胞因子产生的减少。